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Avian inﬂuenza (AI) is a highly contagious and rapidly evolving pathogen of major concern to the poultry industry and human
health. Rapid and accurate detection of avian inﬂuenza virus is a necessary tool for control of outbreaks and surveillance. The
AI virus A/Chicken/Malaysia/5858/2004(H5N1) was used as a template to produce DNA clones of the full-length NS1 genes via
reverse transcriptase synthesis of cDNA by PCR ampliﬁcation of the NS1 region. Products were cloned into pCR2.0 TOPO TA
plasmid and subsequently subcloned into pPICZαA vector to construct a recombinant plasmid. Recombinant plasmid designated
as pPICZαA-NS1 gene was conﬁrmed by PCR colony screening, restriction enzyme digestion, and nucleotide sequence analysis.
The recombinant plasmid was transformed into Pichia pastoris GS115 strain by electroporation, and expressed protein was
identiﬁed by SDS-PAGE and western blotting. A recombinant protein of approximately ∼28kDa was produced. The expressed
protein was able to bind a rabbit polyclonal antibody of nonstructural protein (NS1) avian inﬂuenza virus H5N1. The result
of the western blotting and solid-phase ELISA assay using H5N1 antibody indicated that the recombinant protein produced
retained its antigenicity. This further indicates that Pichia pastoris could be an eﬃcient expression system for a avian inﬂuenza
virus nonstructural (NS1).
1.Introduction
Avian inﬂuenza is a highly contagious viral disease of major
concern to both the poultry industry and human health; the
currently ongoing outbreaks of H5N1 since 1997 have been
unprecedented with over 500 million birds destroyed and
over303humansdead.Thisdevelopmenthasignitedaglobal
fear of imminent Inﬂuenza pandemic. Even though, adop-
tion of vaccination policy as a targeted control or prevention
measures has been generally discouraged by the scientiﬁc
community. However, the need to boost eradication eﬀorts
in order to limit the spread of infections and ensure safety
against international trade embargoes and avoid economic
losses couple with the recent advances in DNA technology
has prompted a re-evaluation of both vaccine strategies and
restrategising of diagnostic tool as an additional eﬀort in
thebattlingagainsthighlypathogenicavianinﬂuenzacontrol
programme [1–3].
Recent advances in molecular DNA biotechnology of
protein expression and production of recombinant viral
protein using various expression systems are becoming
popular, more acceptable, and eﬃcient. The ease with which
genes are manipulated to yield recombinant protein both
for vaccines and diagnostics is fast revolutionalizing the
industry.
Yeast has been endowed with the capacity for easy
posttranslational modiﬁcation of expressed polypeptides
with ease. Their intracellular environment is more suitable
for correct folding of eukaryotic virus protein [4]. The use of
methylotrophic yeast system for foreign protein expression
is increasing dramatically, since the advent of the ﬁrst world
licensed genetically engineered vaccine antigen for hepatitis2 Journal of Biomedicine and Biotechnology
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Figure 1: Agarose gel electrophoresis analysis of two-step RT-PCR
ampliﬁed NS1 gene of AIV using NS1F and NS1R primers.
B for human in 1986 was prepared using yeast recombinant
[5]. In this study, we described the expression of AIV NS1
in Pichia pastoris as an easy tool for generating eﬃcient
expression system that could have potential for serological
diagnostics of AIV without compromising surveillance.
2.Materialsand Methods
InactivatedinﬂuenzaA/chicken/5858/Malaysian2004(H5N1)
was kindly provided by Veterinary Research Institute,
Ipoh, Perak, Malaysia. Trizol RNA extraction method was
employed in the extraction of the viral RNA, under BLS-3
condition. Plasmid DNA extraction and gel puriﬁcation
were employed in accordance with kits manufacturer’s
instructions. The following primers were employed for RT-
PCR: the sense primer P 1 and antisense primer F 5 CTC
GGC TCG AGT ATG GAT TCC AAC ACT GTG 3  and F
5 GAC TGC GGC CGC GCT CTT ATC TCT TGC TCC 3 .
RT-PCR was performed under the following conditions: the
reaction mixture contained in a ﬁnal concentration of 1x
of reaction buﬀer, 5mM of MgCl2,0 . 8 μMo fe a c hp r i m e r
(NS1 F & NS1 R), 0.1mM of dNTP, 2U of AMV reverse
transcriptase, and 5U of recombinant RNasin ribonuclease
inhibitorand100ngofextracted RNAtemplate.The mixture
was initially incubated as follows: brieﬂy, at 45◦Cf o r5 0m i n ,
reverse transcriptase denature at 94◦C for 5min, chilled
at 4◦C, the full denaturation at 94◦Cf o r2 m i n ,a t9 4 ◦C
for 1min, 1mins at 53◦C, 2min at 68◦C for 40 circles
of ampliﬁcation, and 10min at 68◦C for an additional
extension. The PCR products of the full length of AIV
A/Chicken/5858/Malaysian/H5N1 strain NS1 generated was
puriﬁed using GENEALL GEL SV Kit (General Biosystem,
Korea) and subsequently cloned into pCR 2.1 TOPO vector
from TOPO TA Cloning Kit (Invitrogen, USA) according to
manufacturer’s instructions. The ampliﬁed products of the
gene encoding NS1 and pPICZαA expression vector were
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Figure 2: Restriction enzyme analysis of pPICZαA NS1 recombi-
nant plasmid with XhoI and NotI in the Forward and backward
primers, respectively; lanes 2 and 3: vector-3.2kb and insert gene
801bp, lane1: 1kb DNA ladder marker (Fermentas, USA).
digested and subcloned according to standard procedures
[6].
The recombinant pPICZαA-NS1 gene was sequenced
by Macrogen Inc. (Korea), and nucleotide sequences
were analyzed using Bio Edit software program. The
sequence used for comparison or analysis in this study
was A/chicken/Malaysia/5858/2004 (H5N1) (DQ321197.1)
obtained from the GenBank database. The comparison was
done using BLAST (http://www.ncbi.nlm.nih.gov/BLAST/).
The nucleotides of the NS1 gene were compared with
the published sequences from around the world. A 100%
homology was obtained with A/chicken/Malaysia/5858/2004
(H5N1) on NCBI blast (as shown below).
3.Resultsand Discussion
The full length of Inﬂuenza A/Chicken/Malaysia/5858/
2004/(H5N1) NS1 gene of 801bp in size was ampliﬁed by
RT-PCR, sequenced, and cloned into pCR2.0 TOPO TA
cloning vector (Figure 1). Puriﬁed DNA clone of ampliﬁed
full-length NS1 gene was inserted into the expression vector
pPICZαA to generate a recombinant plasmid pPICZαA-
NS1 (Figure 2). After comparing the nucleotide sequence of
NS1 gene derived from the recombinant plasmid pPICZαA-
NS1, its deduced amino acid sequence was found to
be NS1 of H5N1 strain with 100% homology, and the
nucleotidesequencewas found tobesimilar tothat inﬂuenza
A/Chicken/Malaysia/5858/2004 (H5N1) strain with 100%
homology, as shown in (Figure 4).
Immunoblotting results revealed the antigenic band of
∼28kDa NS1 of HPAI using polyclonal antibody against the
28kDa NS1 protein. These ﬁndings strongly suggested that
this protein might be useful as potential antigen for diagnos-
ticsagainstnatural/experimentalHPAIinfections.ThisresultJournal of Biomedicine and Biotechnology 3
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Figure 3: (a) Western blot analysis showing the expressed NS1 recombinant protein of ∼28kDa in expressed GS115 Pichia pastoris strain
using NS1 polyclonal antibody as a primary antibody; expression started at day 7 after methanol induction; (b) SDS-PAGE separating the
proteins into diﬀerent molecular weight prior to transfer to NC membrane and immunodetection.
Table 1: OD650 values of preliminary ELISA for detection of positive NS1 recombinant protein.
Dilution 10 20 40 80 160 320 640 1280 2560 5120 10240 Control
∗Positive 0.924 0.945 0.865 0.729 0.597 0.489 0.325 0.245 0.127 0.096 0.078 0.054
∗∗Negative 0.083 0.080 0.072 0.059 0.051 0.047 0.034 0.030 0.031 0.026 0.334 0.032
∗Positive puriﬁed cell lysate. ∗∗Negative puriﬁed cell lysate.
also indicated successful expression of NS1 gene of avian
inﬂuenza subtype H5N1 designated as GS115/pPICZA/NS1,
an approximately ∼2 8 k D ap r o t e i nc o n ﬁ r m e dv i aw e s t e r n
blot using NS1 polyclonal antibody (Figure 3)a n di n d i r e c t
ELISA using puriﬁed recombinant NS1 protein as coating
antigen (Table 1).
While avian Inﬂuenza(AI)continuestoremind us ofone
of the most fearful diseases threatening the poultry industry
andhumanpopulation,ithasaneconomicburdenandinter-
national trade impacts with serious embargoes; it causes loss
of production and productivity both on individual and the
society[7,8].NS1oftheinﬂuenza virusisa highlyconserved
gene when compared with other encoded proteins, though
it has poor antigenicity. Previous study showed that within
the inﬂuenza virion there was no NS1 protein, but it could
be highly expressed by cells infected with inﬂuenza virus [9].
Therefore, birds vaccinated with inactivated vaccines did not
produce nonstructural protein-speciﬁc antibodies, so NS1
antibodies are only presented in naturally infected birds;
therefore, this could provide a “window” opportunity for
the diﬀerentiation between the vaccinated and the naturally
infected birds, a major challenge to serological surveillance.
In this study, we ampliﬁed and cloned the NS1 gene of an
AI strain A/Chicken/Malaysia/5858/2004 (H5N1), into the
pPICZαA eukaryotic expression system. The recombinant
plasmid designated as GS115-pPICZαA-NS1 was analyzed
by RE digestion, PCR colony screening, and sequencing
analysis.ImmunodetectionusingNS1polyclonalinantibody
in western blot (Figure 3) further conﬁrmed the antigenicity
and correct folding of the recombinant protein. Restriction
enzyme digestion has been a method of choice when
screening a lot of transformants. However, high zeocin
concentration were used for screening of high copy no of
positive Pichia transformants [6]. In conclusion, the NS1
gene of H5N1 subtype inﬂuenza A virus was successfully
cloned and expressed via shake ﬂask following methanol
inductions. These results laid foundation as a preliminaries
ﬁnding for developing an eﬀective diagnostics marker for
inﬂuenza A (H5N1) using recombinant DNA technology.
The inability to diﬀerentiate antibody due to either
natural infection or vaccination has been a serious set-
back hindering the progress of surveillance programme by
interfering with accuracy of diagnosis, and by extension
this can aﬀect the free market ﬂow of poultry and poultry
product at the international market, resulting in a trade
embargoes enforcement. In the present study, it has been
demonstrated that the ability to clone and express NS1
recombinant protein in a shake ﬂask fermentation condition
will oﬀer an armful opportunity for the production of this
NS1 recombinant protein that was shown to speciﬁcally
bind NS1 polyclonal antibodies on Western blot; it has also
shown a potentially promising result in an indirect ELISA
(Table 1) using putative recombinant as coating antigen. It
could diﬀerentiate between infected and vaccinated birds,
in that NS1 antibodies could only be detected in natu-
ral/experimental infections. Based onthe aboveresults, ithas4 Journal of Biomedicine and Biotechnology
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been clearly demonstrated that the diﬀerence between the
positiveandnegative puriﬁedcelllysatesamplesismorethan
threefold diﬀerence; therefore, it is envisage that this may
have a good potential for diagnosis in the case of clinical or
experimental infections or natural outbreaks, even though
this might require further assay using ﬁeld samples. Previous
studies had shown that a diﬀerence equal to or greater than
threefold is enough to demonstrate the establishment of an
infection, while the indirect ELISA is ongoing trials and
validation have been projected that this could be useful at
quarantine stations, where only a single convalescent serum
sample isobtained.This technologywouldoﬀerasimple and
less expensive diagnostic antigen with less hazardous contact
with a whole viral particle commonly encountered in the
conventional method.
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